Cowen and Company’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-379,789
Closed -$1.09M 548
2020
Q4
$1.09M Buy
379,789
+222,466
+141% +$417K 0.1% 74
2020
Q3
$252K Sell
157,323
-41,363
-21% -$62.4K 0.04% 195
2020
Q2
$219K Sell
198,686
-31,814
-14% -$21K 0.04% 197
2020
Q1
$127K Sell
230,500
-2,400
-1% -$2.06K 0.03% 232
2019
Q4
$186K Buy
232,900
+197,900
+565% +$140K 0.02% 213
2019
Q3
$21K Buy
+35,000
New +$20K 0.01% 376

Other funds holding CELUW

Cowen and Company's CELUW Position: Q1 2021 in Review

Cowen and Company sold out of Celularity Inc (CELUW) in Q1 2021, closing a stake of 379,789 shares — an estimated $1.09M sold.

Cowen and Company first reported a position in CELUW in Q3 2019 and held it in 6 quarters. The position peaked at $1.09M in Q4 2020. 23 funds tracked by Wall St. Rank hold CELUW as of Q1 2021.

  • Cowen and Company reported no remaining Celularity Inc position as of Q1 2021 after selling out during the quarter.
  • Cowen and Company sold 379,789 Celularity Inc shares in Q1 2021, an estimated $1.09M.
  • Cowen and Company first reported a position in Celularity Inc in Q3 2019 and held it in 6 quarters.
  • Cowen and Company's Celularity Inc position peaked at $1.09M in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2021.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.